← Back
$CNTA All transactions

Centessa Pharmaceuticals plc

A

$ Value

$0

Shares

40,000

Price

$0

Filed

Jun 24

Insider

Name

Hedley Mary Lynne

Title

CIK

0001340823

Roles

Director

Transaction Details

Transaction Date

2025-06-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

40,000

Footnotes

The shares subject to such option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to continued service as a director through the applicable vesting date. | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Filing Info

Accession No.

0001847903-25-000108

Form Type

4

Issuer CIK

0001847903

Hedley Mary Lynne's History

Date Ticker Type Value
2026-03-01 VEEV M $0
2026-03-01 VEEV M $0
2025-12-15 LLY A $10K
2025-12-01 VEEV M $0
2025-12-01 VEEV M $0
2025-11-17 LLY A $10K
2025-11-17 LLY A $220K
2025-10-20 LLY A $10K
2025-09-15 LLY A $10K
2025-09-01 VEEV M $0

Other Insiders at CNTA (90d)

Insider Bought Sold Last
Weinhoff Gregory M
Chief Business Officer
$2.6M 2026-03-26
Crowley John J
Chief Financial Officer
2026-02-02
Kanes Stephen
Chief Medical Officer
2026-02-02
Anderson Karen M.
Chief People Officer
$6.5M 2026-03-26
HUSSAIN IQBAL J
Chief Legal Officer
$1.0M 2026-02-02
Bush Tia L
Chief Technology & Quality Ofc
2026-02-02
Deferiere Raphael
Chief Accounting Officer
2026-02-02
Accardi Mario Alberto
Chief Executive Officer
2026-02-02